[Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo].
Kostyusheva AP, Brezgin SA, Ponomareva NI, Goptar IA, Nikiforova AV, Gegechkori VI, Poluektova VB, Turkadze KA, Sudina AE, Chulanov VP, Kostyushev DS.
Kostyusheva AP, et al. Among authors: brezgin sa.
Mol Biol (Mosk). 2022 Nov-Dec;56(6):884-891. doi: 10.31857/S002689842206012X.
Mol Biol (Mosk). 2022.
PMID: 36475475
Russian.